NRSN Financials: Neurosense Therapeutics Ltd AI Analysis



Financials

NRSN Financial

Neurosense Therapeutics Ltd

$0.8

6.28%

$0.04

As of today:May 20, 16:54:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.762

Open

$0.8

Day's Range

$0.7603 - $0.8598

52 week range

$0.63 - $2.6

Volume

71.3K

Avg.Volume

207.4K

Dividend yield

EPS (TTM)

-0.62

Market Cap

$28.6M

What is NRSN?

Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company. The firm is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The firm's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease

Features

Markets

News

Breakdown	TTM	12/31/2025	06/30/2025	12/31/2024	09/30/2024	06/30/2024
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	7	4	2	4	0	1
Research & Development	8	6	2	5	1	1
Operating Expenses	15	11	4	9	2	3
Other Non Operating Income (Expenses)	--	--	--	0	--	--
Pretax Income	-15	-11	-4	-10	-2	0
Income Tax Expense	--	--	--	--	--	--
Net Income	-15	-11	-4	-10	-2	0
Net Income Growth	-17%	10%	--	400%	--	-100%
Shares Outstanding (Diluted)	25.48	25.48	25.4	18.6	19.2	18.14
Shares Change (YoY)	37%	37%	40%	8%	89%	17%
EPS (Diluted)	-0.62	-0.43	-0.18	-0.54	-0.11	-0.04
EPS Growth	-38%	-20%	293%	363%	-245%	-86%
Free Cash Flow	-7	-3	-4	-4	--	-5
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	--	0%
EBITDA	-15	-11	-4	-9	--	-3
EBITDA Margin	0%	0%	0%	0%	--	0%
D&A For EBITDA	0	0	0	0	--	0
EBIT	-15	-11	-4	-9	-2	-3
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Breakdown

TTM

12/31/2025

06/30/2025

12/31/2024

09/30/2024

06/30/2024

Revenue

Revenue Growth (YoY)

Cost of Revenue

Gross Profit

Selling, General & Admin

Research & Development

Operating Expenses

Other Non Operating Income (Expenses)

Pretax Income

-15

-11

-4

-10

-2

Income Tax Expense

Net Income

-15

-11

-4

-10

-2

Net Income Growth

-17%

10%

400%

-100%

Shares Outstanding (Diluted)

25.48

25.4

18.6

19.2

18.14

Shares Change (YoY)

37%

40%

89%

17%

EPS (Diluted)

-0.62

-0.43

-0.18

-0.54

-0.11

-0.04

EPS Growth

-38%

-20%

293%

363%

-245%

-86%

Free Cash Flow

-7

-3

-4

-5

Free Cash Flow Per Share

Gross Margin

Operating Margin

Profit Margin

Free Cash Flow Margin

EBITDA

-15

-11

-4

-9

-3

EBITDA Margin

D&A For EBITDA

EBIT

-15

-11

-4

-9

-2

-3

EBIT Margin

Effective Tax Rate

Follow-Up Questions

What are Neurosense Therapeutics Ltd's key financial statements?



According to the latest financial statement (Form-10K), Neurosense Therapeutics Ltd has a total asset of $0, Net loss of $0

What are the key financial ratios for NRSN?



Neurosense Therapeutics Ltd's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Neurosense Therapeutics Ltd's revenue broken down by segment or geography?



Neurosense Therapeutics Ltd largest revenue segment is Banking, at a revenue of 168,627,000 in the most earnings release.For geography, United States is the primary market for Neurosense Therapeutics Ltd, at a revenue of 229,667,000.

Is Neurosense Therapeutics Ltd profitable?



no, according to the latest financial statements, Neurosense Therapeutics Ltd has a net loss of $0

Does Neurosense Therapeutics Ltd have any liabilities?



no, Neurosense Therapeutics Ltd has liability of 0

How many outstanding shares for Neurosense Therapeutics Ltd?



Neurosense Therapeutics Ltd has a total outstanding shares of 0

Neurosense Therapeutics Ltd (NRSN) Financial

NRSN Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is NRSN?

Neurosense Therapeutics Ltd (NRSN) Financial

NRSN Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is NRSN?

NRSN Income

Follow-Up Questions

What are Neurosense Therapeutics Ltd's key financial statements?

What are the key financial ratios for NRSN?

How is Neurosense Therapeutics Ltd's revenue broken down by segment or geography?

Is Neurosense Therapeutics Ltd profitable?

Does Neurosense Therapeutics Ltd have any liabilities?

How many outstanding shares for Neurosense Therapeutics Ltd?